NCT05990998View on ClinicalTrials.gov

A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 20, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

September 1, 2023

Conditions
Tumor Positron-Emission Tomography
Interventions
DRUG

68Ga-DOTATATE and 68Ga-FAPI

Each patient receive a single intravenous injection of 68Ga-FAPI or 68Ga-DOTATATE (2-4mCi) , and undergo PET/CT scan at 40-60 min post injection.

Trial Locations (1)

350005

Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou

All Listed Sponsors
lead

First Affiliated Hospital of Fujian Medical University

OTHER